![AG-636 217903 5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3-iodo-5](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M17659_1634725407.gif?v=1634725408)
Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3-iodo-5
In vitro: Dilute the received ready-to-use iPSC-TSPC cocktail at 1:1000 into your iPSC reprogramming medium to make the iPSC-TSPC media for iPSC induction
9 μM are obtained after 1 day of treatment with Reserpine hydrochloride in JB6 P+ and HepG2-C8 cells
when administered by oral gavage in water once daily beginning at the time of the first collagen immunization
AG-636 217903 5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3-iodo-5AG 636 is a potent, reversible, selective and orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 17 nM. Differential AG 636 activity translated to the in vivo setting, with complete tumor regression observed in a lymphoma model. Dissection of the relationship between uridine availability and response to AG 636 revealed a divergent ability of lymphoma and solid tumor cell lines to survive and grow in the setting of depleted